Zdrowie i gospodarka · 03/11/1998

FDA Announces Guidance on Postmarket Surveillance Protocols Transition

The Food and Drug Administration (FDA) has released a guidance document outlining its plan to transition existing postmarket surveillance protocols, which will impact industry and FDA staff, and describes the criteria used to determine whether to terminate or continue these orders.